Table 3 Number and percentage of sites of cancer, 1989–96: rank and crude incidence (CIR) of each cancer per 100 000 man-years of employment

From: Changes in the geographical and temporal patterns of cancer incidence among black gold miners working in South Africa, 1964–1996

ICD-9

Code

Site of cancer

Cases

%

Rank

CIRs

Recorded in 1964–79

162

RES

Respiratory system

241

13.8

1

9.41

155

HCC

Hepatocellular carcinoma

223

12.8

2

8.71

150

OES

Oesophagus

198

11.3

3

7.73

140–149

BUC

Buccal cavity

94

5.4

4

3.67

202.8, 202.9

NHL

Non-Hodgkin's lymphoma

70

4.0

5

2.73

 

161

LAX

Larynx

66

8.8

6

2.58

 

153–154

COL

Colorectal

58

3.3

7

2.26

204–208

LEU

Leukaemia

57

3.3

8

2.23

201

HDL

Hodgkin's lymphoma

55

3.1

9

2.15

 

203

MYE

Myeloma

52

3.0

10

2.03

 

171

CON

Connective tissue

50

2.9

11

1.95

 

151

STO

Stomach

49

2.8

12

1.91

185

PRS

Prostate

49

2.8

12

  

173

SKI

Skin

40

2.3

14

1.56

 

157

PAN

Pancreas

33

1.9

15

1.29

191–192

CNS

Brain and central nervous system

30

1.7

16

1.17

 

171.9

KPS

Kaposi's sarcoma

28

1.6

17

1.09

 

193–194

END

Thyroid, Other endocrine glands

27

1.5

18

1.05

 

170

BON

Bone

23

1.3

19

0.90

 

172

MEL

Melanoma

21

1.2

20

0.82

 

188

BLD

Bladder

21

1.2

20

 

189

KID

Kidney

16

0.9

22

0.62

 

186

TES

Testis

15

0.9

23

0.59

 

163

PLE

Pleura

14

0.8

24

0.55

 

187

PEN

Penis

10

0.6

25

0.39

 

152

INT

Intestine

9

0.5

26

0.35

 

190

EYE

Eye

7

0.4

27

0.27

 

200

LSA

Lympho- and reticulosarcoma

7

2.6

27

  

175

BRS

Male breast

6

0.3

29

0.23

 

195, 199, 238

USP

Ill defined, unspecified

128

7.4

5.04

 

196–198

PSU

Metastatic but with primary site unknown

46

2.6

1.80

 

a

LYS

Lymphatic systema

132

7.6

5.15

 

b

HIV

HIV/AIDS-relatedb

235

13.5

9.17

 

c

NKN

Inadequate detail/c

175

10.0

6.83

 

N/N

ALL

All cancers

1745

99.9

68.19

 
  1. aICD-9; 200, 201, 202.8, 202.9 are grouped together as cancers of the lymphatic system.
  2. bSubtotals 171.9, 191–192, 201, 202.8, 202.9 and 203 as HIV/AIDS-related (see Table 9).
  3. cSubtotals 195, 196–199 and 238 as inadequate detail/not known.